Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome.

PubMed

Insights

Polymorphonuclear granulocyte (PMN) aggregation, driven by complement activation (C5a), is linked to adult respiratory distress syndrome (ARDS) development. Elevated C5a levels may predict ARDS, supporting corticosteroid use.

Area of Science:

  • Immunology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Polymorphonuclear granulocyte (PMN) aggregation, stimulated by activated complement (C), is implicated in adult respiratory distress syndrome (ARDS) pathogenesis.
  • Aggregated PMNs can lodge in pulmonary vasculature, causing dysfunction and contributing to ARDS.
  • PMN-aggregating activity in plasma correlates with complement fragment C5a levels.

Purpose of the Study:

  • To investigate the correlation between PMN-aggregating activity and ARDS development in at-risk patients.
  • To assess the predictive value of elevated C5a levels for ARDS onset.
  • To evaluate the potential therapeutic implications of PMN aggregation findings.

Main Methods:

  • Plasma samples from 61 patients at risk for ARDS were analyzed for PMN-aggregating activity.
  • C5a levels were measured in plasma samples.
  • Correlation analyses were performed between PMN-aggregating activity, C5a levels, and ARDS development, including subgroup analysis excluding sepsis patients.

Main Results:

  • A strong, significant correlation was observed between plasma PMN-aggregating activity and ARDS development.
  • This correlation remained significant even when patients with sepsis were excluded.
  • Prospective monitoring indicated that elevated C5a levels were a useful predictor of ARDS.

Conclusions:

  • PMN aggregation in response to complement activation plays a significant role in ARDS genesis.
  • Elevated C5a levels serve as a potential early predictor for ARDS.
  • The findings support the use of corticosteroids, known to inhibit PMN aggregation, in managing ARDS.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...